"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","molecule_ch1","taxid_ch1","description","description.1","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_laboratory","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","supplementary_file.1","data_row_count"
"GSM45730","AD-01","GSM45730","Public on Oct 01 2005","Mar 22 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","sample: untreated primary prostate cancer; frozen; Gleason= 6; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45730/GSM45730.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45730/GSM45730.EXP.gz","22283"
"GSM45847","AD-02","GSM45847","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 8; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45847/GSM45847.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45847/GSM45847.EXP.gz","22283"
"GSM45848","AD-03","GSM45848","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 6; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45848/GSM45848.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45848/GSM45848.EXP.gz","22283"
"GSM45849","AD-04","GSM45849","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 7; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45849/GSM45849.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45849/GSM45849.EXP.gz","22283"
"GSM45850","AD-05","GSM45850","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 6; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45850/GSM45850.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45850/GSM45850.EXP.gz","22283"
"GSM45851","AD-06","GSM45851","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 6; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45851/GSM45851.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45851/GSM45851.EXP.gz","22283"
"GSM45852","AD-07","GSM45852","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 8; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45852/GSM45852.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45852/GSM45852.EXP.gz","22283"
"GSM45853","AD-08","GSM45853","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 5; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45853/GSM45853.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45853/GSM45853.EXP.gz","22283"
"GSM45854","AD-09","GSM45854","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 5; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45854/GSM45854.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45854/GSM45854.EXP.gz","22283"
"GSM45855","AD-10","GSM45855","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","untreated human prostate cancer","Homo sapiens","total RNA","9606","untreated primary prostate cancer; frozen; Gleason = 9; tumor cells microdissected from whole mount","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45855/GSM45855.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45855/GSM45855.EXP.gz","22283"
"GSM45856","AI-01","GSM45856","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 7; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45856/GSM45856.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45856/GSM45856.EXP.gz","22283"
"GSM45857","AI-02","GSM45857","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 8; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45857/GSM45857.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45857/GSM45857.EXP.gz","22283"
"GSM45858","AI-03","GSM45858","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 8; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45858/GSM45858.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45858/GSM45858.EXP.gz","22283"
"GSM45859","AI-04","GSM45859","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 8; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45859/GSM45859.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45859/GSM45859.EXP.gz","22283"
"GSM45860","AI-05","GSM45860","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 9; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45860/GSM45860.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45860/GSM45860.EXP.gz","22283"
"GSM45861","AI-06","GSM45861","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 7; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45861/GSM45861.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45861/GSM45861.EXP.gz","22283"
"GSM45862","AI-07","GSM45862","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 8; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45862/GSM45862.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45862/GSM45862.EXP.gz","22283"
"GSM45863","AI-08","GSM45863","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 8; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45863/GSM45863.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45863/GSM45863.EXP.gz","22283"
"GSM45864","AI-09","GSM45864","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 7; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45864/GSM45864.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45864/GSM45864.EXP.gz","22283"
"GSM45865","AI-10","GSM45865","Public on Oct 01 2005","Mar 24 2005","Aug 22 2005","RNA","1","androgen-independent primary human prostate cancer","Homo sapiens","total RNA","9606","androgen-independent primary prostate cancer; frozen; Gleason at initial Dx = 9; tumor cells microdissected from biopsy","","GPL96","Carolyn,J. M.,Best","bestcar@mail.nih.gov","301-451-8544","301-402-8910","Molecular Therapeutics Program","NCI, NIH","37 Convent Drive","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45865/GSM45865.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM45nnn/GSM45865/GSM45865.EXP.gz","22283"
